Literature DB >> 16531786

The metabolic syndrome: a glance at its history.

Panteleimon A Sarafidis1, Peter M Nilsson.   

Abstract

Although the modern era of what we now call the 'metabolic syndrome' or the 'insulin resistance syndrome' seems to have started less than two decades ago with the description of syndrome X by G.M. Reaven in the late 1980s, the history of this syndrome is much longer. In particular, a considerable number of scientists, starting as early as almost 90 years ago, have described the very common coexistence of the various components of the syndrome, including hypertension, and some of them gave several names to this clustering. On the other hand, during the past few years several international organizations have tried to form a reference context of what is included under the terms 'metabolic syndrome' and 'insulin resistance syndrome', proposing various 'definitions' for them. This review summarizes the history of the syndrome, from the early descriptions and other valuable contributions to the recent attempts to define it, as a small piece in honour of the pioneer workers in this field during the twentieth century.

Entities:  

Mesh:

Year:  2006        PMID: 16531786     DOI: 10.1097/01.hjh.0000217840.26971.b6

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  29 in total

Review 1.  Antihypertensive agents, insulin sensitivity, and new-onset diabetes.

Authors:  Pantelis A Sarafidis; Samy I McFarlane; George L Bakris
Journal:  Curr Diab Rep       Date:  2007-06       Impact factor: 4.810

2.  Insulin resistance, microalbuminuria, and chronic kidney disease.

Authors:  Pantelis A Sarafidis; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

Review 3.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

Review 4.  Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome.

Authors:  Pantelis A Sarafidis; Samy I McFarlane; George L Bakris
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

Review 5.  The gut microbiome and metabolic syndrome.

Authors:  Kruttika Dabke; Gustaf Hendrick; Suzanne Devkota
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

Review 6.  Cardiovascular consequences of metabolic syndrome.

Authors:  Johnathan D Tune; Adam G Goodwill; Daniel J Sassoon; Kieren J Mather
Journal:  Transl Res       Date:  2017-01-09       Impact factor: 7.012

Review 7.  Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME.

Authors:  Pantelis A Sarafidis; Antonios A Lazaridis; Gema Ruiz-Hurtado; Luis M Ruilope
Journal:  Nat Rev Endocrinol       Date:  2017-01-20       Impact factor: 43.330

8.  Metabolic syndrome in people with schizophrenia: a review.

Authors:  Marc DE Hert; Vincent Schreurs; Davy Vancampfort; Ruud VAN Winkel
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

9.  Psychopharmacology of tic disorders.

Authors:  Myriam Srour; Paul Lespérance; Francois Richer; Sylvain Chouinard
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2008-08

Review 10.  The metabolic syndrome in women.

Authors:  Rhonda Bentley-Lewis; Katherine Koruda; Ellen W Seely
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2007-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.